Subscribe To
Is jpmorgan diversified return u.s. mid cap equity etf (jpme) a strong etf right now?
The JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) made its debut on 05/11/2016, and is a smart beta exchange traded fund that provides br...
April 17, 2023, 7:38 am
Is invesco s&p 500 equal weight industrials etf (rgi) a strong etf right now?
Designed to provide broad exposure to the Industrials ETFs category of the market, the Invesco S&P 500 Equal Weight Industrials ETF (RGI) is a smart b...
April 17, 2023, 7:38 am
Is wisdomtree u.s. smallcap dividend etf (des) a strong etf right now?
The WisdomTree U.S. SmallCap Dividend ETF (DES) was launched on 06/16/2006, and is a smart beta exchange traded fund designed to offer broad exposure ...
April 17, 2023, 7:38 am
Is iq chaikin u.s. small cap etf (csml) a strong etf right now?
The IQ Chaikin U.S. Small Cap ETF (CSML) was launched on 05/16/2017, and is a smart beta exchange traded fund designed to offer broad exposure to the ...
April 17, 2023, 7:38 am
Is invesco s&p 100 equal weight etf (eqwl) a strong etf right now?
The Invesco S&P 100 Equal Weight ETF (EQWL) was launched on 12/01/2006, and is a smart beta exchange traded fund designed to offer broad exposure to t...
April 17, 2023, 7:38 am
Positive report for gold road resources ltd (elkmf) from canaccord genuity
Canaccord Genuity analyst Tim McCormack upgraded Gold road Resources Ltd (ELKMF – Research Report) to...
April 17, 2023, 7:29 am
Japanese yen weekly forecast: bullish triangle or double top for usd/jpy?
The Japanese yen is at an important crossroads against the US dollar ahead of the release of key Japan inflation data. Which way is USD/JPY headed? Re...
April 17, 2023, 5:59 am
Eth staked withdrawal profile signals a return to $2,200
ETH joined the broader market in the red this morning. However, staking statistics and the withdrawal profile for Monday send bullish signals. The pos...
April 17, 2023, 3:12 am
Frontier medicines presents new preclinical data on its development candidate, fmc-376, a dual krasg12c inhibitor, at the 2023 aacr annual meeting
-FMC-376 is a highly selective, direct dual inhibitor designed to rapidly and completely block both the active and inactive forms of KRASG12C and over...
April 16, 2023, 7:00 pm
Sudan state tv cuts transmission amid clashes
CAIRO (Reuters) – Sudan state television cut its transmission on Sunday afternoon, a move that employees said was aimed at preventing the broadcast ...
April 16, 2023, 6:19 pm
Man gets prison time after feds discover $3.4b in stolen bitcoin hidden inside cheetos popcorn tin
The U.S. attorney for the Southern District of New York has announced that the hacker responsible for the Silk...
April 16, 2023, 5:59 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm
Vaxcyte to host webcast and conference call to discuss results from phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate in adults aged 65 and older and full six-month safety data f
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fide...
April 16, 2023, 5:00 pm